{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:40:16Z","timestamp":1778751616196,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00210-023-02791-0","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T10:02:19Z","timestamp":1698228139000},"page":"3093-3109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nebivolol in oral subacute treatment prevents cardiac post-ischemic dysfunction in rats, but hyperthyroidism reduces this protection: mechanisms involved"],"prefix":"10.1007","volume":"397","author":[{"given":"Mar\u00eda In\u00e9s","family":"Ragone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mat\u00edas","family":"Bayley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romina G.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia E.","family":"Consolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"5","key":"2791_CR1","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10557-021-07205-y","volume":"36","author":"W Al Habeeb","year":"2022","unstructured":"Al Habeeb W, Mrabeti S, Abdelsalam AAI (2022) Therapeutic properties of highly selective \u03b2-blockers with or without additional vasodilator properties: focus on bisoprolol and nebivolol in patients with cardiovascular disease. Cardiovasc Drugs Ther 36(5):959\u2013971. https:\/\/doi.org\/10.1007\/s10557-021-07205-y","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"2791_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/hrt.2010.207365","volume":"97","author":"G Ambrosio","year":"2011","unstructured":"Ambrosio G, Flather MD, B\u00f6hm M, Cohen-Solal A, Murrone A, Mascagni F, Spinucci G, Conti MG, van Veldhuisen DJ, Tavazzi L, Coats AJS (2011) \u03b2-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. Heart 97(3):209\u2013214. https:\/\/doi.org\/10.1136\/hrt.2010.207365","journal-title":"Heart"},{"issue":"7","key":"2791_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/1440-1681.13447","volume":"48","author":"L Audigane","year":"2021","unstructured":"Audigane L, Persello A, Piriou N, Ferron M, Trochu J-N, Lauzier B, Gauthier C, Rozec B (2021) Early nebivolol treatment is beneficial in myocardial infarction in rats partly through \u03b23-adrenoceptor remodelling. Clin Exp Pharmacol Physiol 48(7):1007\u20131015. https:\/\/doi.org\/10.1111\/1440-1681.13447","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"4","key":"2791_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3390\/antiox11040627","volume":"11","author":"JL Bermudez-Gonzalez","year":"2022","unstructured":"Bermudez-Gonzalez JL, Sanchez-Quintero D, Proa\u00f1o-Bernal L, Santana-Apreza R, Jimenez-Chavarria MA, Luna-Alvarez-Amezquita JA, Straface JI, Perez-Partida AM, Berarducci J, Armenta-Moreno JI, Garza-Cruz KJ, Espinola-Zavaleta N, Alexanderson-Rosas E (2022) Role of the antioxidant activity of melatonin in myocardial ischemia-reperfusion injury. Antioxidants 11(4):627\u2013632. https:\/\/doi.org\/10.3390\/antiox11040627","journal-title":"Antioxidants"},{"key":"2791_CR5","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1006\/jmcc.2001.1462","volume":"33","author":"R Bolli","year":"2001","unstructured":"Bolli R (2001) Cardioprotective Function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33:1897\u20131918. https:\/\/doi.org\/10.1006\/jmcc.2001.1462","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"2791_CR6","doi-asserted-by":"publisher","first-page":"H1032","DOI":"10.1152\/ajpheart.00334.2018","volume":"315","author":"E Bovo","year":"2018","unstructured":"Bovo E, Mazurek SR, Zima AV (2018) Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca2+ waves during \u03b2-adrenergic receptor stimulation. Am J Physiol-Heart Circ Physiol 315(4):H1032\u2013H1040. https:\/\/doi.org\/10.1152\/ajpheart.00334.2018","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"2","key":"2791_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.cardiores.2007.03.022","volume":"75","author":"GC Brown","year":"2007","unstructured":"Brown GC, Borutaite V (2007) Nitric oxide and mitochondrial respiration in the heart. Cardiovasc Res 75(2):283\u2013290. https:\/\/doi.org\/10.1016\/j.cardiores.2007.03.022","journal-title":"Cardiovasc Res"},{"key":"2791_CR8","doi-asserted-by":"publisher","first-page":"130098","DOI":"10.1016\/j.bbagen.2022.130098","volume":"5","author":"A Ciocci Pardo","year":"2022","unstructured":"Ciocci Pardo A, Diaz Zegarra LA, Gonz\u00e1lez Arbel\u00e1ez LF, Ib\u00e1\u00f1ez AM, D\u00edaz RG, Aiello EA, Mosca SM (2022) Cardioprotective effects of N-methylacetazolamide mediated by inhibition of L-type Ca2+ channel current. Biochim Biophys Acta Gen Subj 5:130098. https:\/\/doi.org\/10.1016\/j.bbagen.2022.130098","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"5","key":"2791_CR9","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/FJC.0000000000000816","volume":"75","author":"GA Colareda","year":"2020","unstructured":"Colareda GA, Ragone MI, Bonazzola P, Consolini AE (2020) The mKATP channels and protein-kinase C are involved in the cardioprotective effects of genistein on estrogen-deficient rat hearts exposed to ischemia\/reperfusion: energetic study. J Cardiovasc Pharmacol 75(5):460\u2013474. https:\/\/doi.org\/10.1097\/FJC.0000000000000816","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"2791_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1139\/y07-022","volume":"85","author":"AE Consolini","year":"2007","unstructured":"Consolini AE, Ragone MI, Conforti P, Volont\u00e9 MG (2007) Mitochondrial role in ischemia-reperfusion of rat hearts exposed to high-K+ cardioplegia and clonazepam: energetic and contractile consequences. Can J Physiol Pharmacol 85(5):483\u2013496. https:\/\/doi.org\/10.1139\/y07-022","journal-title":"Can J Physiol Pharmacol"},{"issue":"1-2","key":"2791_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11010-015-2501-4","volume":"408","author":"AL de Castro","year":"2015","unstructured":"de Castro AL, Tavares AV, Fernandes RO, Campos C, Conzatti A, Siqueira R, Fernandes TR, Schenkel PC, Sart\u00f3rio CL, Llesuy S, Bell\u00f3-Klein A, da Rosa Araujo AS (2015) T3 and T4 decrease ROS levels and increase endothelial nitric oxide synthase expression in the myocardium of infarcted rats. Mol Cell Biochem 408(1-2):235\u2013243. https:\/\/doi.org\/10.1007\/s11010-015-2501-4","journal-title":"Mol Cell Biochem"},{"key":"2791_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejphar.2019.01.070","volume":"849","author":"RG D\u00edaz","year":"2019","unstructured":"D\u00edaz RG, Escudero DS, Brea MS, Morgan PE, P\u00e9rez NG (2019) p38 mitogen activated protein kinase mediates cardiac Na+\/H+ exchanger inhibition induced by Sildenafil. Eur J Pharmacol 849:96\u2013105. https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.070","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"2791_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2010.11.036","volume":"654","author":"EP Frazier","year":"2011","unstructured":"Frazier EP, Michel-Reher MB, van Loenen P, Sand C, Schneider T, Peters SLM, Michel MC (2011) Lack of evidence that nebivolol is a \u03b23-adrenoceptor agonist. Eur J Pharmacol 654(1):86\u201391. https:\/\/doi.org\/10.1016\/j.ejphar.2010.11.036","journal-title":"Eur J Pharmacol"},{"key":"2791_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fphys.2020.00366","volume":"11","author":"Z Fu","year":"2020","unstructured":"Fu Z, Jiao Y, Wang J, Zhang Y, Shen M, Reiter RJ, Xi Q, Chen Y (2020) Cardioprotective role of melatonin in acute myocardial infarction. Front Physiol 11:366. https:\/\/doi.org\/10.3389\/fphys.2020.00366","journal-title":"Front Physiol"},{"issue":"8","key":"2791_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.amjmed.2014.03.009","volume":"127","author":"IM Grais","year":"2014","unstructured":"Grais IM, Sowers JR (2014) Thyroid and the heart. Am J Med 127(8):691\u2013698. https:\/\/doi.org\/10.1016\/j.amjmed.2014.03.009","journal-title":"Am J Med"},{"issue":"5","key":"2791_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/FJC.0000000000000012","volume":"62","author":"ML Hess","year":"2013","unstructured":"Hess ML, Varma A (2013) The third-generation beta-blocker: have we found the elusive, effective antioxidant? J Cardiovasc Pharmacol 62(5):443\u2013444. https:\/\/doi.org\/10.1097\/FJC.0000000000000012","journal-title":"J Cardiovasc Pharmacol"},{"issue":"7","key":"2791_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00506-7","volume":"18","author":"G Heusch","year":"2021","unstructured":"Heusch G (2021) Myocardial stunning and hibernation revisited. Nat Rev Cardiol 18(7):522\u2013536. https:\/\/doi.org\/10.1038\/s41569-021-00506-7","journal-title":"Nat Rev Cardiol"},{"issue":"5","key":"2791_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.lfs.2007.06.003","volume":"81","author":"T Horinouchi","year":"2007","unstructured":"Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Koike K, Miwa S, Muramatsu I (2007) Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life Sci 81(5):399\u2013404. https:\/\/doi.org\/10.1016\/j.lfs.2007.06.003","journal-title":"Life Sci"},{"key":"2791_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11325-017-1573-7","volume":"22","author":"S Jeddi","year":"2018","unstructured":"Jeddi S, Ghasemi A, Asgari A, Nezami-As A (2018) Role of inducible nitric oxide synthase in myocardial ischemia-reperfusion injury in sleep-deprived rats. Sleep Breath 22:353\u2013359. https:\/\/doi.org\/10.1007\/s11325-017-1573-7","journal-title":"Sleep Breath"},{"issue":"1","key":"2791_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.yjmcc.2005.09.011","volume":"40","author":"SP Jones","year":"2006","unstructured":"Jones SP, Bolli R (2006) The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40(1):16\u201323. https:\/\/doi.org\/10.1016\/j.yjmcc.2005.09.011","journal-title":"J Mol Cell Cardiol"},{"issue":"42","key":"2791_CR21","doi-asserted-by":"publisher","first-page":"e30846","DOI":"10.1097\/MD.0000000000030846","volume":"101","author":"SJ Joo","year":"2022","unstructured":"Joo SJ, Kim SY, Lee JG, Beom JW, Choi J-H, Park HK, Boo KY, Yoon C-H, Lee J-H, Chae JK, Jeong MH, KAMIR-NIH registry investigators (2022) Association of the medical therapy with beta-blockers or inhibitors of renin-angiotensin system with clinical outcomes in patients with mildly reduced left ventricular ejection fraction after acute myocardial infarction. Medicine (Baltimore) 101(42):e30846. https:\/\/doi.org\/10.1097\/MD.0000000000030846","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2791_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/pharmaceutics13020129","volume":"13","author":"DM Kopustinskiene","year":"2021","unstructured":"Kopustinskiene DM, Bernatoniene J (2021) Molecular mechanisms of melatonin-mediated cell protection and signaling in health and disease. Pharmaceutics 13(2):129. https:\/\/doi.org\/10.3390\/pharmaceutics13020129","journal-title":"Pharmaceutics"},{"key":"2791_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00395-021-00893-5","volume":"116","author":"S Lecour","year":"2021","unstructured":"Lecour S, Andreadou I, B\u00f8tker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ, on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225 (2021) IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action. Basic Res Cardiol 116:52. https:\/\/doi.org\/10.1007\/s00395-021-00893-5","journal-title":"Basic Res Cardiol"},{"issue":"7","key":"2791_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/01.RES.0000065441.72685.29","volume":"92","author":"Q Li","year":"2003","unstructured":"Li Q, Guo Y, Xuan YT, Lowenstein C, Stevenson SC, Prabhu SD, Wu W-J, Zhu Y, Bolli R (2003) Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism. Circ Res 92(7):741\u2013748. https:\/\/doi.org\/10.1161\/01.RES.0000065441.72685.29","journal-title":"Circ Res"},{"key":"2791_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00395-021-00868-6","volume":"116","author":"HL Lieder","year":"2021","unstructured":"Lieder HL, Braczko F, Gedik N, Stroetges M, Heusch G, Kleinbongard P (2021) Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes. Basic Res Cardiol 116:27. https:\/\/doi.org\/10.1007\/s00395-021-00868-6","journal-title":"Basic Res Cardiol"},{"issue":"4","key":"2791_CR26","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/153537020623100401","volume":"231","author":"EB Manukhina","year":"2006","unstructured":"Manukhina EB, Downey HF, Mallet RT (2006) Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Exp Biol Med 231(4):343\u2013365. https:\/\/doi.org\/10.1177\/153537020623100401","journal-title":"Exp Biol Med"},{"issue":"4","key":"2791_CR27","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1253\/circj.72.660","volume":"72","author":"G Mercano\u011flu","year":"2008","unstructured":"Mercano\u011flu G, Safran N, Gungor M, Pamukcu B, Uzun H, Sezgin C, Mercano\u011flu F, Fici F (2008) The effects of nebivolol on apoptosis in a rat infarct model. Circ J 72(4):660\u2013670. https:\/\/doi.org\/10.1253\/circj.72.660","journal-title":"Circ J"},{"issue":"24","key":"2791_CR28","first-page":"4872","volume":"19","author":"G Mercano\u011flu","year":"2015","unstructured":"Mercano\u011flu G, Safran N, Ahishali BB, Uzun H, Yalcin A, Mercano\u011flu F (2015) Nitric oxide mediated effects of nebivolol in myocardial infarction: the source of nitric oxide. Eur Rev Med Pharmacol Sci 19(24):4872\u20134889 https:\/\/www.europeanreview.org\/article\/10046","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2791_CR29","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1161\/hh2201.100205","volume":"89","author":"M Murata","year":"2001","unstructured":"Murata M, Akao M, O\u2019Rourke B, Marb\u00e1n E (2001) Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion. Possible mechanism of cardioprotection. Circ Res 89:891\u2013898. https:\/\/doi.org\/10.1161\/hh2201.100205","journal-title":"Possible mechanism of cardioprotection. Circ Res"},{"issue":"6","key":"2791_CR30","doi-asserted-by":"publisher","first-page":"E1319","DOI":"10.1152\/ajpendo.2000.279.6.E1319","volume":"279","author":"K Ojamaa","year":"2000","unstructured":"Ojamaa K, Kenessey A, Shenoy R, Klein I (2000) Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab 279(6):E1319\u2013E1324. https:\/\/doi.org\/10.1152\/ajpendo.2000.279.6.E1319","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2791_CR31","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000446184","volume":"25","author":"M Ozaydin","year":"2016","unstructured":"Ozaydin M, Yucel H, Kocyigit S, Adali MK, Aksoy F, Kahraman F, Uysal BA, Erdogan D, Varol E, Dogan A (2016) Nebivolol versus carvedilol or metoprolol in patients presenting with acute myocardial infarction complicated by left ventricular dysfunction. Med Princ Pract 25:316\u2013322. https:\/\/doi.org\/10.1159\/000446184","journal-title":"Med Princ Pract"},{"issue":"1-2","key":"2791_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11010-011-0791-8","volume":"353","author":"C Pantos","year":"2011","unstructured":"Pantos C, Mourouzis I, Saranteas T, Brozou V, Galanopoulos G, Kostopanagiotou G, Cokkinos DV (2011) Acute T3 treatment protects the heart against ischaemia-reperfusion injury via TR\u03b11 receptor. Mol Cell Biochem 353(1-2):235\u2013241. https:\/\/doi.org\/10.1007\/s11010-011-0791-8","journal-title":"Mol Cell Biochem"},{"issue":"21","key":"2791_CR33","doi-asserted-by":"publisher","first-page":"13340","DOI":"10.3390\/ijms232113340","volume":"23","author":"J Pape","year":"2022","unstructured":"Pape J, Kerp H, Lieder HR, Geist D, H\u00f6nes GS, Moeller LC, Kleinbongard P, F\u00fchrer D (2022) Cardioprotection by hypothyroidism is not mediated by favorable hemodynamics\u2014role of canonical thyroid hormone receptor alpha signaling. Int J Mol Sci 23(21):13340. https:\/\/doi.org\/10.3390\/ijms232113340","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2791_CR34","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1080\/01480545.2021.1908759","volume":"45","author":"S Pekg\u00f6z","year":"2022","unstructured":"Pekg\u00f6z S, Asci H, Erzurumlu Y, Savran M, Ilhan I, Hasseyid N, Ciris M (2022) Nebivolol alleviates liver damage caused by methotrexate via AKT1\/Hif1\u03b1\/eNOS signaling. Drug Chem Toxicol 45(5):2153\u20132159. https:\/\/doi.org\/10.1080\/01480545.2021.1908759","journal-title":"Drug Chem Toxicol"},{"issue":"4","key":"2791_CR35","doi-asserted-by":"publisher","first-page":"H1487","DOI":"10.1152\/ajpheart.00163.2009","volume":"297","author":"G Petrosillo","year":"2009","unstructured":"Petrosillo G, Colantuono G, Moro N, Ruggiero FM, Tiravanti E, Di Venosa N, Fiore T, Paradies G (2009) Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol-Heart Circ Physiol 297(4):H1487\u2013H1493. https:\/\/doi.org\/10.1152\/ajpheart.00163.2009","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"6","key":"2791_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/BF00374809","volume":"429","author":"JE Ponce-Hornos","year":"1995","unstructured":"Ponce-Hornos JE, Bonazzola P, Marengo FD, Consolini AE, M\u00e1rquez MT (1995) Tension-dependent and tension-independent energy components of heart contraction. Pflugers Arch 429(6):841\u2013851. https:\/\/doi.org\/10.1007\/BF00374809","journal-title":"Pflugers Arch"},{"issue":"1","key":"2791_CR37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1074248419872957","volume":"25","author":"MI Ragone","year":"2020","unstructured":"Ragone MI, Bayley M, Colareda BP, Consolini AE (2020) Cardioprotective mechanisms of hypothyroidism on ischemia\/reperfusion in rats and effects of carvedilol: energetic study. J Cardiovasc Pharmacol Ther 25(1):72\u201385. https:\/\/doi.org\/10.1177\/1074248419872957","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"2791_CR38","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1113\/EP085063","volume":"100","author":"MI Ragone","year":"2015","unstructured":"Ragone MI, Bonazzola P, Colareda GA, Consolini AE (2015) Cardioprotective effect of hyperthyroidism on the stunned rat heart during ischaemia-reperfusion: energetics and role of mitochondria. Exp Physiol 100(6):680\u2013697. https:\/\/doi.org\/10.1113\/EP085063","journal-title":"Exp Physiol"},{"key":"2791_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0167-5273(94)90208-9","volume":"43","author":"G Ruf","year":"1994","unstructured":"Ruf G, Trenk D, J\u00e4hnchen E, Roskamm H (1994) Determination of the anti-ischemic activity of nebivolol in comparison with atenolol. Int J Cardiol 43:279\u2013285. https:\/\/doi.org\/10.1016\/0167-5273(94)90208-9","journal-title":"Int J Cardiol"},{"issue":"2","key":"2791_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1476-5381.1988.tb11563.x","volume":"94","author":"H Ruskoaho","year":"1988","unstructured":"Ruskoaho H (1988) Effect of atenolol and pindolol on the phorbol ester-induced coronary vasoconstriction in the isolated perfused heart of the rat. Br J Pharmacol. 94(2):573\u2013583. https:\/\/doi.org\/10.1111\/j.1476-5381.1988.tb11563.x","journal-title":"Br J Pharmacol."},{"issue":"2","key":"2791_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.33696\/cardiology.2.034","volume":"3","author":"R Salie","year":"2022","unstructured":"Salie R, Marais E, Lochner A (2022) Beta 3-adrenergic receptor (\u03b23-AR) activation at the end of sustained ischemia and\/or early reperfusion may prove to be a valuable cardioprotective strategy. J Clin Cardiol 3(2):47\u201350. https:\/\/doi.org\/10.33696\/cardiology.2.034","journal-title":"J Clin Cardiol"},{"key":"2791_CR42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.cardiores.2003.09.019","volume":"61","author":"R Schulz","year":"2004","unstructured":"Schulz R, Kelm M, Heusch G (2004) Nitric oxide in myocardial ischemia\/reperfusion injury. Cardiovasc Res 61:402\u2013413. https:\/\/doi.org\/10.1016\/j.cardiores.2003.09.019","journal-title":"Cardiovasc Res"},{"key":"2791_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190355","volume":"13","author":"FAC Seara","year":"2018","unstructured":"Seara FAC, Maciel L, Barbosa RAQ, Rodrigues NC, Silveira ALB, Marassi MP, Carvalho AB, Hamilton J, Nascimento M, Olivares EL (2018) Cardiac ischemia\/reperfusion injury is inversely affected by thyroid hormones excess or deficiency in male Wistar rats. PLoS One 13:e0190355. https:\/\/doi.org\/10.1371\/journal.pone.0190355","journal-title":"PLoS One"},{"key":"2791_CR44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3390\/ph14121276","volume":"14","author":"M Skrzypiec-Spring","year":"2021","unstructured":"Skrzypiec-Spring M, Urbaniak J, Sapa-Wojciechowska A, Pietkiewicz J, Orda A, Karolko B, Danielewicz R, Bil-Lula I, Wo\u017aniak M, Schulz R, Szel\u0105g A (2021) Matrix metalloproteinase-2 inhibition in acute ischemia-reperfusion heart injury\u2014 cardioprotective properties of carvedilol. Pharmaceuticals 14:1276. https:\/\/doi.org\/10.3390\/ph14121276","journal-title":"Pharmaceuticals"},{"issue":"5","key":"2791_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jash.2012.06.001","volume":"6","author":"D Susic","year":"2012","unstructured":"Susic D, Fares H, Frohlich ED (2012) Nebivolol prevents myocardial fibrosis and diastolic dysfunction in salt-loaded spontaneously hypertensive rats. J Am Soc Hypertens 6(5):316\u2013323. https:\/\/doi.org\/10.1016\/j.jash.2012.06.001","journal-title":"J Am Soc Hypertens"},{"key":"2791_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2170\/jjphysiol.53.411","volume":"53","author":"K Takeuchi","year":"2003","unstructured":"Takeuchi K, Minakawa M, Otaki M, Odagiri S, Itoh K, Murakami A, Yaku H, Kitamura N (2003) Hyperthyroidism causes mechanical insufficiency of myocardium with possibly increased SR Ca2+-ATPase activity. Jpn J Physiol 53:411\u2013416. https:\/\/doi.org\/10.2170\/jjphysiol.53.411","journal-title":"Jpn J Physiol"},{"key":"2791_CR47","doi-asserted-by":"publisher","first-page":"11744","DOI":"10.3390\/ijms222111744","volume":"22","author":"N Venediktova","year":"2021","unstructured":"Venediktova N, Solomadin I, Nikiforova A, Starinets V, Mironova G (2021) Functional state of rat heart mitochondria in experimental hyperthyroidism. Int J Mol Sci 22:11744. https:\/\/doi.org\/10.3390\/ijms222111744","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2791_CR48","doi-asserted-by":"publisher","first-page":"e0160813","DOI":"10.1371\/journal.pone.0160813","volume":"11","author":"AZ Vielma","year":"2016","unstructured":"Vielma AZ, Le\u00f3n L, Fern\u00e1ndez IC, Gonz\u00e1lez DR, Boric MP (2016) Nitric oxide synthase modulates basal and \u03b2-adrenergic-stimulated contractility by rapid and reversible redox-dependent S-nitrosylation of the heart. PLoS One 11(8):e0160813. https:\/\/doi.org\/10.1371\/journal.pone.0160813","journal-title":"PLoS One"},{"issue":"5","key":"2791_CR49","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1530\/EC-19-0096","volume":"8","author":"M Von Hafe","year":"2019","unstructured":"Von Hafe M, Neves JS, Vale C, Borges-Canha M, Leite-Moreira A (2019) The impact of thyroid hormone dysfunction on ischemic heart disease. Endocr Connect 8(5):R76\u2013R90. https:\/\/doi.org\/10.1530\/EC-19-0096","journal-title":"Endocr Connect"},{"key":"2791_CR50","unstructured":"World Health Organization (2021) Cardiovascular diseases (CVDs). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). Accessed 11 June 2021."},{"key":"2791_CR51","doi-asserted-by":"publisher","unstructured":"Xiang M, Lu Y, Xin L, Gao J, Shang C, Jiang Z, Lin H, Fang X, Qu Y, Wang Y, Shen Z, Zhao M, Cui X (2021) Role of oxidative stress in reperfusion following myocardial ischemia and its treatments. Oxid Med Cell Longevity, Article ID 6614009. https:\/\/doi.org\/10.1155\/2021\/6614009","DOI":"10.1155\/2021\/6614009"},{"issue":"1","key":"2791_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1248\/bpb1978.15.25","volume":"15","author":"R Yoshimoto","year":"1992","unstructured":"Yoshimoto R, Hashiguchi Y, Dohmoto H, Hosono M, Iida H, Fujiyoshi T, Ikeda K, Hayashi Y (1992) Effects of a new dihydropyridine derivative, FRC-8653, on blood pressure in conscious spontaneously hypertensive rats. J Pharmacobiodyn 15(1):25\u201332. https:\/\/doi.org\/10.1248\/bpb1978.15.25","journal-title":"J Pharmacobiodyn"},{"key":"2791_CR53","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2174\/1871530320666200508115543","volume":"21","author":"N Yousefzadeh","year":"2021","unstructured":"Yousefzadeh N, Jeddi S, Ghasemi A (2021) Impaired cardiovascular function in male rats with hypo- and hyperthyroidism: involvement of imbalanced nitric oxide synthase levels. Endocr, Metabo Immune Disord Drug Targets 21:526\u2013533. https:\/\/doi.org\/10.2174\/1871530320666200508115543","journal-title":"Endocr, Metabo Immune Disord Drug Targets"},{"issue":"5","key":"2791_CR54","doi-asserted-by":"publisher","first-page":"e98179","DOI":"10.1371\/journal.pone.0098179","volume":"9","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Ding L, Jin Z, Gao G, Li H, Zhang L, Zhang L, Lu X, Hu L, Lu B, Yu X, Hu T (2014) Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling. PLoS One 9(5):e98179. https:\/\/doi.org\/10.1371\/journal.pone.0098179","journal-title":"PLoS One"},{"issue":"1","key":"2791_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2680.1998.1810001.x","volume":"18","author":"J Zwaveling","year":"1998","unstructured":"Zwaveling J, Batink HD, Taguchi K, de Jong J, Michel MC, Pfaffendorf M, van Zwieten A (1998) Thyroid status affects the rat cardiac beta-adrenoceptor system transiently and time-dependently. J Auton Pharmacol 18(1):1\u201311. https:\/\/doi.org\/10.1046\/j.1365-2680.1998.1810001.x","journal-title":"J Auton Pharmacol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02791-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02791-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02791-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:04:40Z","timestamp":1714989880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02791-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["2791"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02791-0","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments were approved by Laboratory Animal Care and Use Committee (CICUAL) of Facultad de Ciencias Exactas, UNLP, on 6 July 2015 with extension on 16 October 2019 up to 2023 (Number 015-5-2015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}